Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Dec 31, 2025
Reporting period
Not applicable
Filed with the SEC
Jan 13, 2026
OfficerGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001193125-26-010470
Filed / recorded
Jan 13, 2026, 2:32 AM UTC
Added to OQRO
Oct 6, 2026, 8:46 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
REPLIGEN CORP
Issuer CIK
730272
Ticker
RGEN
Reporting person
Brian Robb Douglass
Relationship
Officer
Officer title
CHIEF PRODUCT OFFICER
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Dec 31, 2025
Transaction code
A
Shares / units
2,288
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
8,540
Ownership form
Direct
Amendment
No
Footnotes from the filing
Mr. Douglass was awarded 2,288 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in substantially equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock.